Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patients on Chronic Ventilation- a Pilot Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with mechanical ventilation have shown improved weaning rates when enteral tube feeding high in EPA, GLA and antioxidants were fed to patients in the critical care setting.

LTAC Patients on chronic mechanical ventilation will have decreased days an mechanical ventilation, decreased mortality rates and decreased organ failure when fed an enteral product high in EPA, GLA and antioxidants compared to an isotonic high fiber enteral nutrition product.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients

NCT00512122

Critical Illness Starvation

ACTIVE_NOT_RECRUITING PHASE4

Effect of Enteral Nutrition Support for Critically Ill Patients

NCT01464853

Respiratory Distress Syndrome,Adult Acute Lung Injury

TERMINATED PHASE3

Intermittent Versus Continuous Enteral Nutrition in Mechanically Ventilated Patients in the Medical Intensive Care Unit

NCT04437264

Enteral Feeding Nutrition Disorders

COMPLETED NA

Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory Failure

NCT01174316

Respiratory Failure Neuromuscular Disease Chest Wall Disorder +2 more

WITHDRAWN NA

Oxidative Lipidomic Biomarkers During Mechanical Ventilation in Critically Ill Patients (OXY-BAL).

NCT05412810

Mechanical Ventilation Complication Hyperoxia

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Lung Injury Mechanical Ventilation Complication Dietary Modification

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oxepa

Other: Therapeutic nutrition with EPA, GLA and antioxidants.

Group Type EXPERIMENTAL

Oxepa

Intervention Type OTHER

Therapeutic nutrition with EPA, GLA\< and antioxidants

Jevity 1.5

Other: Jevity 1.5 Complete Balanced Nutrition with Fiber .

Group Type ACTIVE_COMPARATOR

Jevity 1.5

Intervention Type OTHER

Complete balanced nutrition with a unique fiber blend

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxepa

Therapeutic nutrition with EPA, GLA\< and antioxidants

Intervention Type OTHER

Jevity 1.5

Complete balanced nutrition with a unique fiber blend

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\>18 years old with Respiratory failure on mechanical ventilation with failure to wean Diagnosis of ARDS (Acute respiratory Distress Syndrome) Bilateral infiltrates -

Exclusion Criteria

History Of pulmonary fibrosis, Terminal illness/ malignancies, \<28 day life expectancy, Hemodialysis, Active bleeding or bleeding disorder: DIC ( Disseminated intravascular Coagulation), Sickle Cell Anemia, Hemophilia Hemorrhagic or ischemic stroke, Liver failure, Head trauma with Glasgow coma scale score of \<5, Immunosuppression: WBC(White Blood Cell Count) \<5000, HIV positive, use of immunosuppressant drugs, Pregnancy, and Heart Failure with EF(Ejection Fraction) \<35%

\-

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No